Page 786 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

764 PART IV Specific Malignancies in the Small Animal Patient

495. Warren A, Center S, McDonough S, et al.: Histopathologic fea- 516. Tzannes S, Hammond MF, Murphy S, et al.: Owners ‘perception of
tures, immunophenotyping, clonality, and eubacterial fluorescence their cats’ quality of life during COP chemotherapy for lymphoma,
in situ hybridization in cats with lymphocytic cholangitis/cholan- J Feline Med Surg 10:73–81, 2008.
VetBooks.ir 496. Gouldin ED, Mullin C, Morges M, et al.: Feline discrete high- 517. Pope KV, Tun AE, McNeill CJ, et al.: Outcome and toxicity assess-
giohepatitis, Vet Pathol 48:627–641, 2011.
ment of feline small cell lymphoma: 56 cases (2000-2010), Vet Med
grade gastrointestinal lymphoma treated with surgical resection
Sci 1:51–62, 2015.
and adjuvant CHOP-based chemotherapy: retrospective study of 518. Stein TJ, Pellin M, Steinberg H, et al.: Treatment of feline gastro-
20 cases, Vet Comp Oncol 15:328–335, 2017. intestinal small-cell lymphoma with chlorambucil and glucocorti-
497. Pohlman LM, Higginbotham ML, Welles EG, et al.: Immunophe- coids, J Am Anim Hosp Assoc 46:413–417, 2010.
notypic and histologic classification of 50 cases of feline gastroin- 519. Dutelle AL, Bulman-Fleming JC, Lewis CA, et al.: Evaluation of
testinal lymphoma, Vet Pathol 46:259–268, 2009. lomustine as a rescue agent for cats with resistant lymphoma, J
498. Sapierzynski R, Jankowska U, Jagielski D, et al.: Large granular Feline Med Surg 14:694–700, 2012.
lymphoma in six cats, Pol J Vet Sci 18:163–169, 2015. 520. Collette SA, Allstadt SD, Chon EM, et al.: Treatment of feline
499. Ezura K, Ezura K, Nomura I, et al.: Natural killer-like T cell lym- intermediate- to high-grade lymphoma with a modified university
phoma in a cat, Vet Rec 154:268–270, 2004. of Wisconsin-Madison protocol: 119 cases (2004-2012), Vet Comp
500. Krick EL, Little L, Patel R, et al.: Description of clinical and path- Oncol 14(Suppl 1):136–146, 2016.
ological findings, treatment and outcome of feline large granular 521. Limmer S, Eberle N, Nerschbach V, et al.: Treatment of feline lym-
lymphocyte lymphoma (1996-2004), Vet Comp Oncol 6:102–110, phoma using a 12-week, maintenance-free combination chemo-
2008. therapy protocol in 26 cats, Vet Comp Oncol 14(Suppl 1):21–31,
501. Roccabianca P, Vernau W, Caniatti M, et al.: Feline large granular 2016.
lymphocyte (LGL) lymphoma with secondary leukemia: primary 522. Waite AH, Jackson K, Gregor TP, et al.: Lymphoma in cats treated
intestinal origin with predominance of a CD3/CD8(alpha) pheno- with a weekly cyclophosphamide-, vincristine-, and prednisone-
type, Vet Pathol 43:15–28, 2006. based protocol: 114 cases (1998-2008), J Am Vet Med Assoc
502. Congress ‘99: what’s new in the treatment of lymphoma? J Small 242:1104–1109, 2013.
Anim Pract 40:51, 1999. 523. Hadden AG, Cotter SM, Rand W, et al.: Efficacy and toxicosis
503. Gieger T: Alimentary lymphoma in cats and dogs, Vet Clin North of VELCAP-C treatment of lymphoma in cats, J Vet Intern Med
Am Small Anim Pract 41:419–432, 2011. 22:153–157, 2008.
504. Kiselow MA, Rassnick KM, McDonough SP, et al.: Outcome of 524. Jeglum KA, Whereat A, Young K: Chemotherapy of lymphoma in
cats with low-grade lymphocytic lymphoma: 41 cases (1995-2005), 75 cats, J Am Vet Med Assoc 190:174–178, 1987.
J Am Vet Med Assoc 232:405–410, 2008. 525. Milner RJ, Peyton J, Cooke K, et al.: Response rates and survival
505. Fondacaro JVRK, Carpenter JL, et al.: Feline gastrointestinal lym- times for cats with lymphoma treated with the University of Wis-
phoma: 67 cases, Eur J Comp Gastroenterol 4:199, 1999. consin-Madison chemotherapy protocol: 38 cases (1996-2003),
506. Gabor LJ, Canfield PJ, Malik R: Haematological and biochemi- J Am Vet Med Assoc 227:1118–1122, 2005.
cal findings in cats in Australia with lymphosarcoma, Aust Vet J 526. Mooney SC, Hayes AA, MacEwen EG, et al.: Treatment and prog-
78:456–461, 2000. nostic factors in lymphoma in cats: 103 cases (1977-1981), J Am
507. Gerou-Ferriani M, McBrearty AR, Burchmore RJ, et al.: Agarose Vet Med Assoc 194:696–702, 1989.
gel serum protein electrophoresis in cats with and without lym- 527. Moore AS, Cotter SM, Frimberger AE, et al.: A comparison of
phoma and preliminary results of tandem mass fingerprinting anal- doxorubicin and COP for maintenance of remission in cats with
ysis, Vet Clin Pathol 40:159–173, 2011. lymphoma, J Vet Intern Med 10:372–375, 1996.
508. Daniaux LA, Laurenson MP, Marks SL, et al.: Ultrasonographic 528. Simon D, Eberle N, Laacke-Singer L, et al.: Combination chemo-
thickening of the muscularis propria in feline small intestinal small therapy in feline lymphoma: treatment outcome, tolerability, and
cell T-cell lymphoma and inflammatory bowel disease, J Feline Med duration in 23 cats, J Vet Intern Med 22:394–400, 2008.
Surg 16:89–98, 2014. 529. Krick EL, Cohen RB, Gregor TP, et al.: Prospective clinical trial to
509. Evans SE, Bonczynski JJ, Broussard JD, et al.: Comparison of compare vincristine and vinblastine in a COP-based protocol for
endoscopic and full-thickness biopsy specimens for diagnosis of lymphoma in cats, J Vet Intern Med 27:134–140, 2013.
inflammatory bowel disease and alimentary tract lymphoma in 530. Kristal O, Lana SE, Ogilvie GK, et al.: Single agent chemotherapy
cats, J Am Vet Med Assoc 229:1447–1450, 2006. with doxorubicin for feline lymphoma: a retrospective study of 19
510. Zwingenberger AL, Marks SL, Baker TW, et al.: Ultrasonographic cases (1994-1997), J Vet Intern Med 15:125–130, 2001.
evaluation of the muscularis propria in cats with diffuse small intes- 531. Peaston AE, Maddison JE: Efficacy of doxorubicin as an induction
tinal lymphoma or inflammatory bowel disease, J Vet Intern Med agent for cats with lymphosarcoma, Aust Vet J 77:442–444, 1999.
24:289–292, 2010. 532. Poirier VJ, Thamm DH, Kurzman ID, et al.: Liposome-encap-
511. Jergens AE, Willard MD, Allenspach K: Maximizing the diagnostic sulated doxorubicin (Doxil) and doxorubicin in the treatment of
utility of endoscopic biopsy in dogs and cats with gastrointestinal vaccine-associated sarcoma in cats, J Vet Intern Med 16:726–731,
disease, Vet J 214:50–60, 2016. 2002.
512. Kleinschmidt S, Harder J, Nolte I, et al.: Chronic inflammatory 533. Teske E, van Straten G, van Noort R, et al.: Chemotherapy with
and non-inflammatory diseases of the gastrointestinal tract in cats: cyclophosphamide, vincristine, and prednisolone (COP) in cats
diagnostic advantages of full-thickness intestinal and extraintestinal with malignant lymphoma: new results with an old protocol, J Vet
biopsies, J Feline Med Surg 12:97–103, 2010. Intern Med 16:179–186, 2002.
513. Awaysheh A, Wilcke J, Elvinger F, et al.: Evaluation of supervised 534. Vajdovich P, Psader R, Toth ZA, et al.: Use of the argyrophilic
machine-learning algorithms to distinguish between inflammatory nucleolar region method for cytologic and histologic examination
bowel disease and alimentary lymphoma in cats, J Vet Diagn Invest of the lymph nodes in dogs, Vet Pathol 41:338–345, 2004.
28:679–687, 2016. 535. Teske E, van Lankveld AJ, Rutteman GR: Intraperitoneal antineo-
514. Sawa M, Yabuki A, Setoguchi A, et al.: Development and applica- plastic drug delivery: experience with a cyclophosphamide, vincris-
tion of multiple immunofluorescence staining for diagnostic cytol- tine and prednisolone protocol in cats with malignant lymphoma,
ogy of canine and feline lymphoma, Vet Clin Pathol 44:580–585, Vet Comp Oncol 12:37–46, 2014.
2015. 536. Elliott J, Finotello R: A dexamethasone, melphalan, actinomycin-
515. Malik R, Gabor LJ, Foster SF, et al.: Therapy for Australian cats D and cytarabine chemotherapy protocol as a rescue treatment for
with lymphosarcoma, Aust Vet J 79:808–817, 2001. feline lymphoma, Vet Comp Oncol 16:E144–E151, 2018.